Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

4 Stocks To Watch: CWEI, EBIO, GIMO, PGNX

Published 08/16/2016, 12:54 AM
Updated 07/09/2023, 06:31 AM

It was a pretty good day on Wall Street on Monday. The markets ran early, consolidated midday, and backed off, but gave back just a little bit of it. The stocks we follow, particular new, recent issues, really had a big day. We’ll just have to take a look at the charts and get a clear picture of them.

Clayton Williams Energy, Inc. (NYSE:CWEI), a swing trade of ours, officially made it 200% since our recommendation. It was under 20 back in May, and had reached 60 at one point. It had a 60.18 high, up 3.62 to 59.42, or 6.5%, on 528,013, with 5.9 days to cover. It may still get to the 69-70 range at the top of the channel. It is extended, so be careful.

Eleven Biotherapeutics, Inc. (NASDAQ:EBIO), one of our swing trades, extended nicely, reaching 5.77 before backing off, up 64 cents, or 13 1/2%, on 9.1 million shares. That was the biggest volume in two weeks. I like the way this is acting, and the 8-dollar target may be at hand, but it will take a real push because this stock is only at the 5.35 range.

Gigamon Inc. (NYSE:GIMO) has been great since the April time period when it quickly got to the first target and pulled back, then moved dramatically from 28 up to 47 on Monday, up 91 cents closing at 46.82, or 2%, on 665,386 share traded. It’s in a nice rising channel and I do think it has a shot of getting up toward the 52 range. There’s 4.27 days to cover.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) is doing great. After the pop and flag, it broke out, had a little, 3-day wedge, and on Monday, it popped again, up 23 cents to 6.91, or 3.4%, on 1.4 million shares. That’s the best volume in four days. I’m thinking this stock is headed up toward 8-8 1/2. It has 3.67 days to cover.

Stocks on the long side included Acacia Communications, Inc. (NASDAQ:ACIA), Alarm.com Holdings, Inc. (NASDAQ:ALRM), The Chemours Company (NYSE:CC), Callon Petroleum Company (NYSE:CPE), Clayton Williams Energy, Inc. (CWEI), Eleven Biotherapeutics, Inc. (EBIO), Exact Sciences Corporation (NASDAQ:EXAS), Five9, Inc. (NASDAQ:FIVN), Flotek Industries Inc. (NYSE:FTK), Gigamon Inc. (GIMO), GoPro, Inc. (NASDAQ:GPRO), Healthways, Inc. (NASDAQ:HWAY), Micron Technology, Inc. (NASDAQ:MU), Nektar Therapeutics (NASDAQ:NKTR), Oclaro, Inc. (NASDAQ:OCLR), Ocular Therapeutix, Inc. (NASDAQ:OCUL), Progenics Pharmaceuticals, Inc. (PGNX), Resolute Energy Corporation (NYSE:REN), U.S. Silica Holdings, Inc. (NYSE:SLCA), Talend SA (NASDAQ:TLND), Twilio, Inc. (NYSE:TWLO), Twitter, Inc. (NYSE:TWTR), VelocityShares 3x Long Crude Oil ETN (NYSE:UWTI), Weibo Corporation (NASDAQ:WB), and Yirendai Ltd. (NYSE:YRD).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.